Substance / Medication

Ipecacuanha

Overview

Active Ingredient
ipecac
RxNorm CUI
5975

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Clinical Trials

65 trials linked to this intervention

65
Total Trials
6
Recruiting
21
With Results

Research Evidence

Published studies and systematic reviews

Sort:
Effects of lerisetron, a new 5-HT3 receptor antagonist, on ipecacuanha-induced emesis in healthy volunteers.
Cooper Mark, Sologuren Ander, Valiente Roman et al. · Arzneimittelforschung · 2002
PMID: 12404884Observational
Molecular cloning of an O-methyltransferase from adventitious roots of Carapichea ipecacuanha.
Cheong Bo Eng, Takemura Tomoya, Yoshimatsu Kayo et al. · Biosci Biotechnol Biochem · 2011
PMID: 21228475Other
Evolution of the 5.8S nrDNA gene and internal transcribed spacers in Carapichea ipecacuanha (Rubiaceae) within a phylogeographic context.
Queiroz Camila de Sousa, Batista Flávia Reis de Carvalho, de Oliveira Luiz Orlando · Mol Phylogenet Evol · 2011
PMID: 21300163Other
Clonal diversity and conservation genetics of the medicinal plant Carapichea ipecacuanha (Rubiaceae).
de Oliveira Luiz Orlando, Venturini Bruna Afonso, Rossi Ana Aparecida Bandini et al. · Genet Mol Biol · 2010
PMID: 21637610OtherFull text (PMC)
Molecular phylogeography of Carapichea ipecacuanha, an amphitropical shrub that occurs in the understory of both semideciduous and evergreen forests.
de Oliveira Luiz Orlando, Rossi Ana Aparecida Bandini, Martins Ernane Ronie et al. · Mol Ecol · 2010
PMID: 20298468Other
Genetic diversity and geographic differentiation of disjunct Atlantic and Amazonian populations of Psychotria ipecacuanha (Rubiaceae).
Rossi Ana Aparecida Bandini, de Oliveira Luiz Orlando, Venturini Bruna Afonso et al. · Genetica · 2009
PMID: 18679809Other
The new beta-D-glucosidase in terpenoid-isoquinoline alkaloid biosynthesis in Psychotria ipecacuanha.
Nomura Taiji, Quesada Alfonso Lara, Kutchan Toni M · J Biol Chem · 2008
PMID: 18927081OtherFull text (PMC)
Boosting the anti-tumor activity of natural killer cells by caripe 8 - A Carapichea ipecacuanha isolated cyclotide.
List Julia, Gattringer Jasmin, Huszarek Sophie et al. · Biomed Pharmacother · 2024
PMID: 38976957Preclinical

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Ipecacuanha (substance)
SNOMED CT
372591000
UMLS CUI
C0022046
RxNorm CUI
5975

Clinical Data

This intervention maps to 2 entities in the Healos knowledge graph.

2
Conditions
0
Biomarkers
0
Specialists
0
Symptoms
65
Clinical Trials

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.